Differential effects of xamoterol and verapamil on ventricular rate regulation in patients with chronic atrial fibrillation
- 1 October 1992
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 124 (4) , 917-923
- https://doi.org/10.1016/0002-8703(92)90973-y
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation.Heart, 1990
- Ventricular control and exercise performance in chronic atrial fibrillation: Effects of diltiazem verapamilJournal of the American College of Cardiology, 1990
- The effect of oral dosing of xamoterol on systolic time intervals in man and xamoterol plasma concentrations in heart failure patients.British Journal of Clinical Pharmacology, 1990
- Chronotropic Response to Exercise in Patients with Atrial FibrillationPacing and Clinical Electrophysiology, 1990
- Effects of Atenolol, Verapamil, and Xamoterol on Heart Rate and Exercise Tolerance in Digitalised Patients with Chronic Atrial FibrillationJournal of Cardiovascular Pharmacology, 1989
- Twenty four hour ambulatory electrocardiography in patients with chronic atrial fibrillation.BMJ, 1986
- Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.BMJ, 1985
- Effect of Corwin (ICI 118587) on resting and exercise heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.Heart, 1984
- The Anaerobic Threshold Measurement to Evaluate Exercise Performance1,2American Review of Respiratory Disease, 1984
- Verapamil improves exercise capacity in chronic atrial fibrillation: Double-blind crossover studyAmerican Heart Journal, 1983